Karyopharm Therapeutics Inc. (KPTI)

NASDAQ: KPTI · Real-Time Price · USD

3.540

-0.200 (-5.35%)

At close: Apr 1, 2025, 4:00 PM

3.685

+0.145 (4.09%)

After-hours: Apr 1, 2025, 4:48 PM EDT

Karyopharm Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	145.24	146.03	157.07	209.82	108.09	Upgrade
Revenue Growth (YoY)	-0.55%	-7.03%	-25.14%	94.12%	164.31%	Upgrade
Cost of Revenue	6.01	4.94	5.21	3.4	2.71	Upgrade
Gross Profit	139.23	141.09	151.86	206.42	105.38	Upgrade
Selling, General & Admin	115.44	131.88	145.4	143.85	126.42	Upgrade
Research & Development	143.23	138.75	148.66	160.84	150.81	Upgrade
Operating Expenses	258.67	270.63	294.06	304.69	277.23	Upgrade
Operating Income	-119.44	-129.54	-142.2	-98.27	-171.85	Upgrade
Interest Expense	-37.42	-23.82	-25	-26.05	-27.14	Upgrade
Interest & Investment Income	7.4	10.94	2.36	0.58	2.82	Upgrade
Other Non Operating Income (Expenses)	28.4	-0.36	-0.08	-0.09	0.21	Upgrade
EBT Excluding Unusual Items	-121.07	-142.78	-164.92	-123.82	-195.96	Upgrade
Other Unusual Items	44.7	-	-	-	-	Upgrade
Pretax Income	-76.37	-142.78	-164.92	-123.82	-195.96	Upgrade
Income Tax Expense	0.06	0.32	0.37	0.27	0.31	Upgrade
Net Income	-76.42	-143.1	-165.29	-124.09	-196.27	Upgrade
Net Income to Common	-76.42	-143.1	-165.29	-124.09	-196.27	Upgrade
Shares Outstanding (Basic)	8	8	5	5	5	Upgrade
Shares Outstanding (Diluted)	8	8	5	5	5	Upgrade
Shares Change (YoY)	11.02%	39.51%	8.85%	4.41%	16.28%	Upgrade
EPS (Basic)	-9.41	-18.79	-30.28	-24.75	-40.87	Upgrade
EPS (Diluted)	-14.00	-18.79	-30.30	-24.75	-40.87	Upgrade
Free Cash Flow	-127.63	-92.72	-149.67	-107.33	-160.38	Upgrade
Free Cash Flow Per Share	-15.10	-12.18	-27.42	-21.40	-33.39	Upgrade
Gross Margin	95.86%	96.62%	96.68%	98.38%	97.50%	Upgrade
Operating Margin	-82.24%	-88.71%	-90.53%	-46.84%	-159.00%	Upgrade
Profit Margin	-52.62%	-97.99%	-105.23%	-59.14%	-181.59%	Upgrade
Free Cash Flow Margin	-87.88%	-63.50%	-95.29%	-51.15%	-148.38%	Upgrade
EBITDA	-119.1	-129.01	-141.58	-97.48	-170.88	Upgrade
EBITDA Margin	-82.01%	-88.34%	-90.14%	-46.46%	-158.10%	Upgrade
D&A For EBITDA	0.34	0.53	0.62	0.79	0.97	Upgrade
EBIT	-119.44	-129.54	-142.2	-98.27	-171.85	Upgrade
EBIT Margin	-82.24%	-88.71%	-90.53%	-46.84%	-159.00%	Upgrade
Revenue as Reported	145.24	146.03	157.07	209.82	108.09	Upgrade

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q